Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.260 | 3.400 | 0.140 |
Shares | 96.740 | 96.740 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 42.711 | 37.516 |
Price to Book | 5.696 | 5.365 |
Price to Sales | 6.822 | 5.581 |
Price to Cash Flow | 33.167 | 27.701 |
Dividend Yield | 0.459 | 0.595 |
5 Years Earnings Growth | 23.328 | 19.762 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 93.240 | 96.130 |
Basic Materials | 6.760 | 4.357 |
Number of long holdings: 28
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sun Pharma | INE044A01036 | 12.99 | 1,795.30 | +0.86% | |
Max Healthcare Institute | INE027H01010 | 6.26 | 999.95 | +0.99% | |
Divi's Labs | INE361B01024 | 6.21 | 5,998.35 | +0.36% | |
Poly Medicure Ltd | INE205C01021 | 5.38 | 2,582.15 | -0.27% | |
Lupin | INE326A01037 | 5.12 | 2,071.35 | +1.39% | |
Lonza Group AG | US54338V1017 | 4.55 | 58.38 | -0.48% | |
Cipla | INE059A01026 | 4.54 | 1,486.50 | +1.43% | |
Krishna Institute of Medical Sciences | INE967H01025 | 3.99 | 595.25 | +1.93% | |
Jupiter Life Line Hospitals | INE682M01012 | 3.54 | 1,520.95 | -1.37% | |
Mankind Pharma | INE634S01028 | 3.51 | 2,551.55 | -0.04% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SBI Magnum Balanced Fund Direct Div | 715.85B | 14.52 | 11.32 | 13.24 | ||
SBI Magnum Balanced Fund Direct Gro | 715.85B | 14.52 | 11.32 | 13.32 | ||
SBI Magnum Balanced Fund Regular Gr | 715.85B | 13.87 | 10.55 | 12.37 | ||
SBI Magnum Balanced Reg Div Payout | 715.85B | 13.87 | 10.55 | 12.29 | ||
SBI Bluechip Fund Regular Dividend | 504.47B | 14.89 | 13.14 | 13.33 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review